Jeff Evanson - Net Worth and Insider Trading
Jeff Evanson Net Worth
The estimated net worth of Jeff Evanson is at least $256,686 dollars as of 2024-11-06. Jeff Evanson is the CHIEF COMMERCIAL OFFICER of Outlook Therapeutics Inc and owns about 40,423 shares of Outlook Therapeutics Inc (OTLK) stock worth over $256,686. Details can be seen in Jeff Evanson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeff Evanson has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeff Evanson
Jeff Evanson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeff Evanson owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Jeff Evanson’s form 4 insider trades.
Insider Ownership Summary of Jeff Evanson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-03-07 | Chief Commercial Officer |
Jeff Evanson Latest Holdings Summary
Jeff Evanson currently owns a total of 1 stock. Jeff Evanson owns 40,423 shares of Outlook Therapeutics Inc (OTLK) as of March 7, 2024, with a value of $256,686.
Latest Holdings of Jeff Evanson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2024-03-07 | 40,423 | 6.35 | 256,686 |
Holding Weightings of Jeff Evanson
Jeff Evanson Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeff Evanson has made a total of 6 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years, including 2 buys and 4 sells. The most-recent trade in Outlook Therapeutics Inc is the acquisition of 3,124 shares on March 7, 2024, which cost Jeff Evanson around $26,243.
Insider Trading History of Jeff Evanson
- 1
Jeff Evanson Trading Performance
GuruFocus tracks the stock performance after each of Jeff Evanson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeff Evanson is 8.57%. GuruFocus also compares Jeff Evanson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeff Evanson within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeff Evanson's insider trading performs compared to the benchmark.
Performance of Jeff Evanson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.17 | | | | | |
| Relative Return to S&P 500(%) | 7.87 | | | | | |
Jeff Evanson Ownership Network
Ownership Network List of Jeff Evanson
Ownership Network Relation of Jeff Evanson
Jeff Evanson Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Jeff Evanson is the Chief Commercial Officer of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include CFO and Secretary Lawrence A Kenyon , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Jeff Evanson made 1 insider transaction in Outlook Therapeutics Inc (OTLK) with a net purchase of 62,484. Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net purchase of 5,000 shares made by Lawrence A Kenyon , a net purchase of 1,882 shares made by Yezan Munther Haddadin ,
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 5,000 shares, with a net purchase of 5,000 shares. During the past 18 months, 0 shares of Outlook Therapeutics Inc (OTLK) were sold and 10,006 shares were bought by its insiders, resulting in a net purchase of 10,006 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Jeff Evanson Mailing Address
Above is the net worth, insider trading, and ownership report for Jeff Evanson. You might contact Jeff Evanson via mailing address: C/o Oncobiologics, Inc., 7 Clarke Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
